Novartis AG (SWX:NOVN)
96.06
-0.37 (-0.38%)
Jul 15, 2025, 5:37 PM CET
Novartis AG Employees
Novartis AG had 75,883 employees as of December 31, 2024. The number of employees decreased by 174 or -0.23% compared to the previous year.
Employees
75,883
Change (1Y)
-174
Growth (1Y)
-0.23%
Revenue / Employee
619.98K CHF
Profits / Employee
149.79K CHF
Market Cap
188.93B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 75,883 | -174 | -0.23% |
Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,249 |
Lonza Group AG | 18,944 |
Alcon | 25,599 |
Galderma Group AG | 6,545 |
Sandoz Group AG | 22,049 |
Straumann Holding AG | 11,815 |
Sonova Holding AG | 18,366 |
Ypsomed Holding AG | 2,644 |
Novartis AG News
- 1 day ago - Divi’s Laboratories shares fall 3% after MSN wins Entresto patent case - Business Upturn
- 2 days ago - Why Novartis Is Still A 'Buy' After 15% Surge - Seeking Alpha
- 4 days ago - Novartis loses patent challenge to block MSN Pharma’s generic Entresto - Seeking Alpha
- 4 days ago - Novartis loses bid to block US Entresto generic through 2026 - Reuters
- 5 days ago - Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS) - Benzinga
- 7 days ago - Novartis (NVS) Gains Approval for Infant Malaria Treatment - GuruFocus
- 7 days ago - Novartis wins approval for first malaria drug for newborns - Financial Times
- 7 days ago - Novartis wins Swiss approval for Coartem Baby, first malaria drug for infants and young children - Seeking Alpha